Đang chuẩn bị liên kết để tải về tài liệu:
EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Targeting deubiquitinases (DUBs) has emerged as a promising avenue for anticancer drug development. However, the effect and mechanism of pan-DUB inhibitor EOAI on non-small cell lung cancer (NSCLC) remains to be studied. |